The Associated Press @AP
A much-debated drug for Lou Gehrig's disease won U.S. approval, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. https://t.co/JyZWeia4kL — PolitiTweet.org